These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 14960741

  • 1. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.
    Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP.
    N Engl J Med; 2004 Feb 12; 350(7):647-54. PubMed ID: 14960741
    [Abstract] [Full Text] [Related]

  • 2. Use of B-type natriuretic peptide for the management of women with dyspnea.
    Mueller C, Laule-Kilian K, Scholer A, Frana B, Rodriguez D, Schindler C, Marsch S, Perruchoud AP.
    Am J Cardiol; 2004 Dec 15; 94(12):1510-4. PubMed ID: 15589006
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea.
    Mueller C, Laule-Kilian K, Schindler C, Klima T, Frana B, Rodriguez D, Scholer A, Christ M, Perruchoud AP.
    Arch Intern Med; 2006 May 22; 166(10):1081-7. PubMed ID: 16717170
    [Abstract] [Full Text] [Related]

  • 4. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH, Steyerberg EW, Boomsma F, van Saase JL, Deckers JW, Hoogsteden HC, Lindemans J, van den Meiracker AH.
    Am Heart J; 2008 Jul 22; 156(1):71-7. PubMed ID: 18585499
    [Abstract] [Full Text] [Related]

  • 5. The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea.
    Mueller C, Laule-Kilian K, Frana B, Rodriguez D, Rudez J, Scholer A, Buser P, Pfisterer M, Perruchoud AP.
    J Intern Med; 2005 Jul 22; 258(1):77-85. PubMed ID: 15953135
    [Abstract] [Full Text] [Related]

  • 6. Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease.
    Mueller C, Laule-Kilian K, Frana B, Rodriguez D, Scholer A, Schindler C, Perruchoud AP.
    Am Heart J; 2006 Feb 22; 151(2):471-7. PubMed ID: 16442916
    [Abstract] [Full Text] [Related]

  • 7. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
    Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, Breathing Not Properly Multinational Study Investigators.
    N Engl J Med; 2002 Jul 18; 347(3):161-7. PubMed ID: 12124404
    [Abstract] [Full Text] [Related]

  • 8. Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting.
    Lam LL, Cameron PA, Schneider HG, Abramson MJ, Müller C, Krum H.
    Ann Intern Med; 2010 Dec 07; 153(11):728-35. PubMed ID: 21135296
    [Abstract] [Full Text] [Related]

  • 9. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.
    Strunk A, Bhalla V, Clopton P, Nowak RM, McCord J, Hollander JE, Duc P, Storrow AB, Abraham WT, Wu AH, Steg G, Perez A, Kazanegra R, Herrmann HC, Aumont MC, McCullough PA, Maisel A.
    Am J Med; 2006 Jan 07; 119(1):69.e1-11. PubMed ID: 16431187
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
    Reichlin T, Potocki M, Breidthardt T, Noveanu M, Hartwiger S, Burri E, Klima T, Stelzig C, Laule K, Mebazaa A, Christ M, Mueller C.
    Am J Med; 2009 Nov 07; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M, Brueckmann M, Ahmad-Nejad P, Lang S, Wolpert C, Elmas E, Kaelsch T, Gruettner J, Weiss C, Borggrefe M, Neumaier M.
    Int J Cardiol; 2009 Jun 26; 135(2):165-74. PubMed ID: 18603317
    [Abstract] [Full Text] [Related]

  • 12. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R, Rapid Emergency Department Heart Failure Outpatient Trial investigators.
    J Am Coll Cardiol; 2004 Sep 15; 44(6):1328-33. PubMed ID: 15364340
    [Abstract] [Full Text] [Related]

  • 13. Short-term mortality risk in emergency department acute heart failure.
    Peacock WF, Nowak R, Christenson R, DiSomma S, Neath SX, Hartmann O, Mueller C, Ponikowski P, Möckel M, Hogan C, Wu AH, Richards M, Filippatos GS, Anand I, Ng LL, Daniels LB, Morgenthaler N, Anker SD, Maisel AS.
    Acad Emerg Med; 2011 Sep 15; 18(9):947-58. PubMed ID: 21906204
    [Abstract] [Full Text] [Related]

  • 14. Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department.
    Chung T, Sindone A, Foo F, Dwyer A, Paoloni R, Janu MR, Wong H, Hall J, Freedman SB.
    Am Heart J; 2006 Nov 15; 152(5):949-55. PubMed ID: 17070166
    [Abstract] [Full Text] [Related]

  • 15. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N, Cobbaert CM, Middelhoff CJ, Bantje TA, van Guldener C.
    Eur J Intern Med; 2009 May 15; 20(3):301-6. PubMed ID: 19393498
    [Abstract] [Full Text] [Related]

  • 16. Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study.
    Christ M, Laule-Kilian K, Hochholzer W, Klima T, Breidthardt T, Perruchoud AP, Mueller C.
    J Am Coll Cardiol; 2006 Nov 07; 48(9):1808-12. PubMed ID: 17084254
    [Abstract] [Full Text] [Related]

  • 17. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS, Sørli D, Omland T, Knudsen CW, Westheim A, Wu AH, Steg PG, McCord J, Nowak RM, Hollander JE, Storrow AB, Abraham WT, McCullough PA, Maisel A.
    Am J Cardiol; 2009 Oct 01; 104(7):966-71. PubMed ID: 19766765
    [Abstract] [Full Text] [Related]

  • 18. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD.
    J Am Coll Cardiol; 2010 May 11; 55(19):2062-76. PubMed ID: 20447528
    [Abstract] [Full Text] [Related]

  • 19. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 20. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
    Berdagué P, Caffin PY, Barazer I, Vergnes C, Sedighian S, Letrillard S, Pilossof R, Goutorbe F, Piot C, Reny JL.
    Am Heart J; 2006 Mar 03; 151(3):690-8. PubMed ID: 16504634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.